Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens.
about
Transplant Tolerance Induction in Newborn Infants: Mechanisms, Advantages, and Potential StrategiesPost-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantationBone marrow cell graft engineering: from bench to bedside.Efficacy and limitations of cyclophosphamide-induced tolerance against alphaGal antigen.Sequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.The allure and peril of hematopoietic stem cell transplantation: overcoming immune challenges to improve success.A reduction of recipient regulatory T cells by cyclophosphamide contributes to an anti-tumor effect of nonmyeloablative allogeneic stem cell transplantation in mice.Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation.Novel therapeutics for the treatment of graft-versus-host disease.Treatment of hematological malignancies with nonmyeloablative, HLA-haploidentical bone marrow transplantation and high dose, post-transplantation cyclophosphamideHematopoietic chimerism and transplantation tolerance: a role for regulatory T cells.Cross-species transplantation tolerance: rat bone marrow-derived cells can contribute to the ligand for negative selection of mouse T cell receptor V beta in chimeras tolerant to xenogeneic antigens (mouse + rat----mouse).HLA-haploidentical blood or marrow transplantation with high-dose, post-transplantation cyclophosphamide.Donor bone marrow cells are essential for iNKT cell-mediated Foxp3+ Treg cell expansion in a murine model of transplantation tolerance.Antigen and lymphopenia-driven donor T cells are differentially diminished by post-transplantation administration of cyclophosphamide after hematopoietic cell transplantation.Haploidentical SCT: the mechanisms underlying the crossing of HLA barriers.Immune tolerance in recipients of combined haploidentical bone marrow and kidney transplantation.Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.Post-transplant cyclophosphamide, a promising anti-graft versus host disease prophylaxis: where do we stand?Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo.Induction of Pancreatic Islet Graft Acceptance: The Role of Antigen Presenting CellsRapamycin and T cell costimulatory blockade as post-transplant treatment promote fully MHC-mismatched allogeneic bone marrow engraftment under irradiation-free conditioning therapy.Cyclophosphamide-induced tolerance in kidney transplantation avoids long-term immunosuppressive therapy.
P2860
Q26752512-DE747ED2-5D2B-4CCB-B87B-BE8866DD60DCQ26852474-6368CF6D-B6FA-47B7-96BC-01F8586BD2B3Q30666969-3F7C3E39-532C-4CEE-AA6D-C95973B5103FQ33223831-FACE7B1E-CE96-4506-885D-51DD9336A774Q33246284-CD34548C-060C-485F-B24A-6194A76FB7A5Q33724352-82D6A911-7455-4D5D-9704-BAC383169BD9Q33829731-3B23F861-7F00-4D54-9C1C-9D97F392A0D4Q34170816-D52BFE08-772F-44D6-A8F5-28CB32C96AB6Q34841838-7B426B3C-8820-4EB8-9719-80C989282583Q35478934-A91F4691-8215-4EF0-B5AC-AE078D37FB51Q35928393-A4807487-3A2D-4191-B0EE-0D2BA2ED96CEQ36230864-5351E857-8675-4CB7-8FEF-B51F853BC867Q36253363-BBE326EA-BBF7-4B1C-9B0B-70E65EC0E87BQ36262113-BFF340EF-F226-416C-A08C-F2AA63912AE6Q37721898-DD830698-2039-44E6-B7BF-E91935B19C9FQ38190856-F1A63E4E-7AE2-4FA2-A75D-EDB4FC576118Q38514510-37BC769F-646C-4574-BED5-D122B2E468D1Q39176256-BB048C9D-84F4-404D-BDDB-563516E95679Q39232385-B0DF45F4-3E3B-403B-AAB4-AAAF1ABECAB4Q39290128-8FE30B87-17FC-413F-94C4-A56B27447E87Q41770384-9AE8E410-91A5-4A1D-9481-B5B0F12AA97CQ44050407-2BD95359-2804-42FE-A170-0A110737D033Q50145136-1C3876DE-39E6-45DC-B5DA-D56361B093BA
P2860
Intrathymic clonal deletion of V beta 6+ T cells in cyclophosphamide-induced tolerance to H-2-compatible, Mls-disparate antigens.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Intrathymic clonal deletion of ...... tible, Mls-disparate antigens.
@ast
Intrathymic clonal deletion of ...... tible, Mls-disparate antigens.
@en
type
label
Intrathymic clonal deletion of ...... tible, Mls-disparate antigens.
@ast
Intrathymic clonal deletion of ...... tible, Mls-disparate antigens.
@en
prefLabel
Intrathymic clonal deletion of ...... tible, Mls-disparate antigens.
@ast
Intrathymic clonal deletion of ...... tible, Mls-disparate antigens.
@en
P2093
P2860
P356
P1476
Intrathymic clonal deletion of ...... tible, Mls-disparate antigens.
@en
P2093
P2860
P304
P356
10.1084/JEM.171.1.97
P407
P577
1990-01-01T00:00:00Z